Air pollution is a worldwide public health issue and it is associated with millions of premature
deaths due to cancer, thrombosis, and pulmonary and cardiovascular diseases. Thrombosis …

Background Although airborne fine particulate matter (PM) pollution has been demonstrated
as an independent risk factor for pulmonary and cardiovascular diseases, their currently …

Particulate airborne pollution is associated with increased cardiopulmonary morbidity.
Microparticles are extracellular vesicles shed by cells upon activation or apoptosis involved …

Ambient environmental air pollutants include gaseous and particulate components. In
polluted air, especially particulate matter seems responsible for cardiovascular …

The lung is an important site of extramedullary platelet formation, and megakaryocytes in the
lung participate in immune responses in addition to platelet production. In acute lung injury …

Increasingly, evidence suggests a role for a systemic procoagulant state in the pathogenesis
of cardiac dysfunction subsequent to inhalation of airborne particulate matter. The authors …

A state of the art lecture titled “Megakaryocytes in the Lung” was presented at the London
International Society on Thrombosis and Haemostasis congress in 2022. This lecture …

Background Epidemiological studies have shown associations of particulate matter (PM)
exposure with hypercoagulability and thrombosis. Extracellular circulating histones have …

Air pollution is a growing public health concern of global significance. Acute and chronic
exposure is known to impair cardiovascular function, exacerbate disease and increase …

Exposure to particulate air pollution is associated with acute and chronic cardiovascular
morbidity and mortality. The mechanisms involved in these effects are not fully elucidated …